comparemela.com

Latest Breaking News On - Anhui zhifei longcom biopharmaceutical co - Page 8 : comparemela.com

China approves one more COVID-19 vaccine for emergency use - China News

2021-03-17 10:05:50 GMT2021-03-17 18:05:50(Beijing Time) Xinhua English BEIJING, March 17 (Xinhua) China has approved the emergency use of a self-developed recombinant protein subunit vaccine against COVID-19, its main developer, the Institute of Microbiology under the Chinese Academy of Sciences, said on Wednesday. The vaccine (CHO Cells) completed phase-1 and phase-2 clinical trials in October 2020. Results support the safety and immunogenicity of this vaccine, with no severe adverse reactions reported. The level of neutralizing antibody elicited by the vaccine is comparable to other COVID-19 recombinant protein vaccines and mRNA vaccines in the world, according to an institute statement. Researchers have been holding phase-3 trials since November 2020 in China, Uzbekistan, Pakistan, Ecuador and Indonesia, planning to enroll up to 29,000 adults.

China approves one more COVID-19 vaccine for emergency use

news China approves one more COVID-19 vaccine for emergency use Yuan Quan,unreguser © Provided by N.C.N. Limited A medical worker prepares a vaccine at a temporary COVID-19 vaccination site at a company in the ZPark Phase 2 in Haidian District of Beijing, capital of China, Feb. 22, 2021. (Xinhua/Ren Chao) BEIJING, March 17 (Xinhua) China has approved the emergency use of a self-developed recombinant protein subunit vaccine against COVID-19, its main developer, the Institute of Microbiology under the Chinese Academy of Sciences, said on Wednesday. The vaccine (CHO Cells) completed phase-1 and phase-2 clinical trials in October 2020. Results support the safety and immunogenicity of this vaccine, with no severe adverse reactions reported.

Covid-19: Moderna Begins Testing Its Vaccine in Children

Covid-19: Moderna Begins Testing Its Vaccine in Children Last Updated March 21, 2021, 10:46 a.m. ETMarch 21, 2021, 10:46 a.m. ET Europe’s drug regulator is pushing back on fears about the AstraZeneca vaccine. And more than a dozen countries have suspended the use of the vaccine, although Australia, Britain and Thailand are moving ahead with it. Brittany Siguenza, 5, watching her mother receive a dose of the Moderna vaccine in Revere, Mass., on Friday.Credit.CJ Gunther/EPA, via Shutterstock The drug company Moderna has begun a study that will test its Covid vaccine in children under 12, including babies as young as six months, the company said on Tuesday.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.